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Abstract
Background—Recent postmortem studies have demonstrated pathological changes, including
Purkinje cell loss, in the cerebellum in essential tremor (ET). Toxic exposures that compromise
cerebellar tissue could lower the threshold for developing ET. Ethanol is a well-established cerebellar
toxin, resulting in Purkinje cell loss.
Objective—To test whether higher baseline ethanol consumption is a risk factor for the subsequent
development of incident ET.
Methods—Lifetime ethanol consumption was assessed at baseline (1994-1995) in a prospective,
population-based study in central Spain of 3,285 elderly participants, 76 of whom developed incident
ET by follow-up (1997-1998).
Results—In a Cox proportional hazards model adjusting for cigarette pack-years, depressive
symptoms and community, the baseline number of drink-years was marginally associated with higher
risk of incident ET (relative risk, RR = 1.003, p = 0.059). In an adjusted Cox model, highest baseline
drink-year quartile doubled the risk of incident ET (RR = 2.29, p = 0.018) while other quartiles were
associated with more modest elevations in risk (RR3rd quartile = 1.82 [p = 0.10], RR2nd quartile = 1.75
[p = 0.10], RR1st quartile = 1.43 [p = 0.34] vs. non-drinkers [RR = 1.00]). With each higher drink-year
quartile, risk of incident ET increased an average of 23% (p = 0.01, test for trend).
Conclusions—Higher levels of chronic ethanol consumption increased the risk of developing ET.
Ethanol is often used for symptomatic relief; studies should explore whether higher consumption
levels are a continued source of underlying cerebellar neurotoxicity in patients who already manifest
this disease.
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Essential tremor (ET) is one of the most common neurological disorders.1 The underlying
disease mechanisms are not clear; however, evidence from clinical and neuroimaging studies
implicates a disorder of the cerebellum.2, 3 Recent postmortem studies demonstrate
pathological changes in the ET cerebellum, including swellings of Purkinje cell axons and
Purkinje cell loss.4-6 With this understanding, one would expect that exposures that
compromise cerebellar tissue might predispose to ET or lower the threshold for developing
ET. Ethanol is a well-established cerebellar toxin.7-9 We hypothesized that higher baseline
ethanol consumption would be a risk factor for the subsequent development of incident ET.
Methods
The Neurological Disorders in Central Spain (NEDICES) is a population-based survey of major
age-associated conditions of the elderly (!65 years) from three communities in Spain (Las
Margaritas, Lista and Arévalo).10 Detailed accounts of the study population and survey
methods have been reported.10-12 Signed informed consent was obtained upon enrollment.
As documented,10 the baseline in-person evaluation (1994 - 1995) included a questionnaire
(demographic, medical, lifestyle information). Data on smoking were collected; prior results
suggest that smoking may decrease the risk of incident ET.12 Hence, a priori, cigarette pack-
years were a major potential confounder of interest. A general neurologic examination included
assessments of action tremor and the motor portion of the Unified Parkinson’s Disease Rating
Scale (UPDRS).13 Diagnostic criteria for ET have been described.10
As detailed elsewhere, the follow-up evaluation (1997 - 1998) was similar to the baseline
evaluation and the diagnostic approach to ET was identical.10
Follow-up data were available on 3,942 of 5,278 baseline participants (Figure). We excluded
657 participants with incomplete data on ethanol consumption, leaving 3,285 participants.
These remaining 3,285 participants were similar to the original 5,278 participants in mean (±
SD) baseline age (73.5 ± 6.6 vs. 74.3 ± 7.0 years), gender (56.8% vs. 57.3% women) and
education (12.7% vs. 12.1% illiterate).
There were 76 incident ET cases, including 40 who had in-person baseline examinations and
did not have ET on those examinations and 36 who did not have in-person baseline
examinations. Baseline handwriting samples of these 36 were reviewed by a senior neurologist
(E.D.L.) and none had tremor that was in the ET range (all had Bain and Findley14 handwriting
tremor scores !1, which are within the range of normal).15 Furthermore, each of the 36 was
re-interviewed during the follow-up evaluation to establish that the onset of their tremor had
been after the baseline assessment.
In statistical analyses (SPSS version 16.0, Chicago, IL), baseline pack-years = packs of
cigarettes smoked/day x years smoked. One drink-year = one drink of ethanol (one 360 mL
can of beer or one 120 mL glass of wine or 30 mL of liquor) per day/year. We used Cox
proportional hazards models to estimate the relative risk (RR) of incident ET, beginning with
an unadjusted model and then included covariates associated with both baseline smoking and
incident ET in univariate analyses.
Results
The 3,285 participants included 1,838 (56.0%) who were ethanol drinkers (>0 drink-years) at
baseline. These differed from non-drinkers in several respects (e.g., age, Table 1). Mean (SD)
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follow-up was 3.3 ± 0.8 years (range = 0.1 - 6.6 years). The 76 incident ET cases differed from
3,209 controls by baseline depressive symptoms and cigarette pack-years (Table 1).
Median number of baseline drink-years was 57% higher (26.3 vs. 16.8) in incident ET cases
vs. controls, although this difference did not achieve statistical significance (Table 1). In
analyses that stratified by cigarette pack-year tertile, the number of drink-years within each
stratum was higher in incident ET cases than controls, although this difference only reached
significance in the highest cigarette pack-year tertile (p = 0.035, Table 1).
In an unadjusted Cox proportional hazards model, baseline number of drink-years was not
associated with risk of incident ET (RR = 1.001, 95% CI = 0.998 - 1.004, p = 0.52). There were
a number of obvious confounding factors (esp. cigarette smoking). In a Cox model that adjusted
for cigarette pack-years, depressive symptoms and community, baseline number of drink-years
were marginally associated with higher risk of incident ET (RR = 1.003, 95% CI = 1.000 -
1.006, p = 0.059, i.e., for every 10 unit increase in drink years, the risk of ET increased 3%).
Adding an additional covariate, use of an antidepressant medication, to the model did not
change the results (RR = 1.003, 95% CI = 1.000 - 1.006, p = 0.055).
In a Cox proportional hazards model that adjusted for cigarette pack-years, depressive
symptoms and community, highest baseline drink-year quartile was associated with a doubling
of risk of incident ET (RR = 2.29, 95% CI = 1.15 - 4.54, p = 0.018, Table 2). With each
advancing quartile, the risk of incident ET increased (Table 2), and a test for trend indicated
that with each higher drink-year quartile, the risk of incident ET increased on average by 23%
(RR = 1.23, 95% CI = 1.05 - 1.43, p = 0.01).
ET cases included 40 who had had an in-person baseline examination and 36 who did not.
When we included in the adjusted Cox proportional hazards analysis a covariate indicating the
type of baseline evaluation, results did not change (RR = 2.29, 95% CI = 1.15 - 4.54, p = 0.018).
Discussion
The highest quartile of baseline ethanol consumption was associated with substantially higher
risk of developing incident ET while other quartiles were associated with more modest
elevations in risk. There was a dose-response effect; with each advancing higher drink-year
quartile, the risk of developing incident ET increased an average of 23%.
One interpretation of these data is that ethanol, a known cerebellar toxin, lowers the threshold
for developing ET, which seems to be a disorder involving the cerebellum. Ethanol is a well-
established cerebellar toxin and a variety of noxious changes have been demonstrated including
reductions in Purkinje cell number and density, regression of Purkinje cell dendritic arbors,
and loss of synapses.7-9, 16 Although the effects are most pronounced in the cerebellar vermis,
they are not restricted to that cerebellar region, and gross atrophy of cerebellar hemispheres
has been demonstrated in many studies.17, 18 The long term intake of moderate doses of daily
ethanol in humans has been shown to result in significant Purkinje cell loss.19 Recent
postmortem studies of ET have indicated that there are cerebellar changes including Purkinje
cell axonal swellings, Purkinje cell loss, and possibly gliosis in excess of that seen in age-
matched control brains.4-6 In some brains, more extensive cerebellar degeneration is evident,
including changes in the dendate nucleus.20 A two-hit model has been proposed for a variety
of diseases of the central nervous system, with the basic concept being that an initial exposure/
injury to a distinct neuronal population can produce permanent and cumulative neurotoxicity
and enhance vulnerability to a second set of insults involving that same neuronal population.
21-24
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One possibility is that the 76 NEDICES participants who developed incident ET between the
baseline and follow-up evaluations had pre-clinical ET at baseline (i.e., enough tremor for them
to notice but not enough for a diagnosis of ET) and they were self-medicating with ethanol
(i.e., they were drinking more ethanol in order to lessen this tremor). We think this is unlikely.
First, when asked at baseline whether their arms or legs shook, they answered “no”, indicating
that they did not notice tremor. Second, each of the 76 had an in-person neurological assessment
or a detailed assessment of handwriting and each was found to have negligible if any tremor.
Finally, the assessment of baseline handwriting samples in 36 incident ET cases indicated that
a baseline tremor of 1 rather than 0 was not associated with more ethanol consumption ("2 =
10.27 [p = 0.25] for baseline handwriting tremor score vs. baseline drink-year quartile),
indicating that even this negligible amount of tremor did not have as a correlate greater
consumption of ethanol.
NEDICES participants in the highest quartile of ethanol consumption were consuming on
average 3 - 4 standard drinks per day; this amount is consistent with prior clinical definitions
of heavy ethanol consumption (!3 standard drinks/day in women and !4 in men)25 and
commensurate with chronic ethanol intake levels shown to be associated with Purkinje cell
degeneration in humans.19
This study had limitations. The findings may be generalized only to ET cases age !65 years.
Also, our mean follow-up time was modest and longer follow-up would likely have resulted
in more incident ET cases and greater study power.
Our findings have possible clinical implications. We observed that the highest levels of chronic
ethanol consumption seemed to increase the risk of developing ET. The mechanism, though
not established, could involve cumulative cerebellar neurotoxicity. By implication, it is
conceivable that chronic ethanol use, while symptomatically beneficial for patients, could be
a continued source of underlying cerebellar neurotoxicity and, therefore, be a continued
contributor to the progression of the disease. If this were the case, then patients would need to
be cautioned about the potential deleterious effects of high levels of ethanol on their underlying
disease. Future studies should explore these issues.
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Figure 1. Flow chart from the Neurological Disorders in Central Spain (NEDICES) Study
Louis et al. Page 7











































Louis et al. Page 8
Table 1
Baseline characteristics (ethanol drinkers vs. non-drinkers and incident ET cases vs. control subjects)








Age in years (mean ± SD) 73.1 ± 6.5*** 74.1 ± 6.7 73.7 ± 6.4 73.5 ± 6.6
Gender (women) 648 (35.3%)*** 1,219 (84.2%) 45 (59.2%) 1,822 (56.8%)
Educational level
!Illiterate



































Cigarette Pack-years 24.3 ± 32.0*** 5.0 ± 18.0 9.3 ± 17.8** 16.0 ± 28.6
Depressive symptoms (Screening
question “Do you suffer from
depression?”)
417 (22.7%)*** 428 (29.7%) 28 (36.8%)* 817 (25.5%)
Use of an antidepressant
medication

















Baseline Drink-years mean ± SD,
(median)
61.9 ± 70.6 (26.3)a 56.7 ± 71.0 (16.8)
Baseline Drink-years by smoking
strata
!Non-smokers
!Cigarette pack-year tertile 1
!Cigarette pack-year tertile 2
!Cigarette pack-year tertile 3
34.5 ± 51.1 (0.0)





31.7 ± 55.8 (0.0)
80.4 ± 69.9 (78.0)
91.8 ± 73.0 (104.0)






p < 0.001 (ethanol drinkers vs. non-drinkers; incident ET cases vs. control subjects).
a
Mann Whitney test
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Table 2
Risk of ET by baseline drink-year quartile
Baseline Drink-Year Quartile Unadjusted Model
* RR (95% CI), p
value Adjusted Model
** RR (95% CI), p value
Non-drinkers Reference Reference
Lowest quartile (#40.7) 1.13 (0.55 - 2.33), p = 0.73 1.43 (0.68 - 2.98), p = 0.34
2nd quartile (40.8 - 110.0) 1.31 (0.68 - 2.52), p = 0.42 1.75 (0.89 - 3.42), p = 0.10
3rd quartile (110.1 - 138.0) 1.27 (0.63 - 2.54), p = 0.50 1.82 (0.89 - 3.74), p = 0.10
Highest quartile (>138.0) 1.49 (0.77 - 2.86), p = 0.24 2.29 (1.15 - 4.54), p = 0.018
The reference category was non-drinkers.
In analyses stratified by gender, comparing highest baseline drink-year quartile to non-drinkers, adjusted RRmen = 2.93 (95% CI = 0.79 - 10.81, p = 0.11)
and adjusted RRwomen = 1.66 (95% CI = 0.50 - 5.51, p = 0.41).
We created two education strata (high education = primary or secondary studies vs. low education = can read or write or illiterate). In analyses stratified
by education, comparing highest baseline drink-year quartile to non-drinkers, adjusted RRhigh education = 2.19 (95% CI = 0.81 - 5.94, p = 0.13) and
adjusted RRlow education = 2.25 (95% CI = 0.86 - 5.85, p = 0.097).
In an analysis of daily number of drinks at baseline (rather than drink-years), when those in the highest category (>5 drinks/day) were compared to non-
drinkers, RR = 1.94 (95% CI = 0.26 - 14.67, p = 0.52). When those who had 3 - 5 drinks/day were compared to non-drinkers, RR = 2.19 (95% CI = 0.66
- 7.31, p = 0.20). When those who had 1 - 2 drinks/day were compared to non-drinkers, RR = 1.30 (95% CI = 0.78 - 2.17, p = 0.31).
*
Unadjusted Cox proportional hazards model.
**
Cox proportional hazards model adjusting for cigarette pack-years, depressive symptoms and community
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